Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Subcutaneous Mepolizumab Delivery Devices in Healthy Subjects
NCT03014674Phase 3Completed
- Sponsor
- GSK
- Start
- Jan 2017
- Primary completion
- Aug 2017
- Modality
- Monoclonal Antibodies
- Countries
- 3
01
Overview
A Phase 3 trial of mepolizumab in asthma, sponsored by GSK. Started Jan 2017; status: completed.
02
Drugs
mepolizumab
03
Conditions
asthma
Beyond the preview
Go deeper on NCT03014674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03014674.